Page last updated: 2024-08-26

bosentan anhydrous and Experimental Mammary Neoplasms

bosentan anhydrous has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, LD; Castillo, CI; Dréau, D; Eddy, JM; Jewell, AN; McDermott, KA; Swamydas, M; Wyan, H1

Other Studies

1 other study(ies) available for bosentan anhydrous and Experimental Mammary Neoplasms

ArticleYear
The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancer.
    Cancer investigation, 2010, Volume: 28, Issue:9

    Topics: Animals; Antihypertensive Agents; Bone Neoplasms; Bosentan; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Inflammation Mediators; Interleukin-17; Interleukin-1alpha; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Burden; Tumor Necrosis Factor-alpha

2010